Nasoflo Dosage & Drug Information

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Concise Prescribing Info

Contents

Fluticasone propionate

Indications/Uses

Prevention & treatment of allergic rhinitis. Prevention of recurrence of nasal polyps after surgical removal.

Click to view Nasoflo detailed prescribing information

Dosage/Direction for Use

Adult & childn ≥12 yr Usual dose: 2 sprays in each nostril once daily, preferably in the morning, or 1 spray in each nostril bid. Max: 4 sprays in each nostril daily. Maintenance: 1 spray in each nostril once daily. Start maintenance dose a few days after (4-7 days) initial therapy. Childn 4-11 yr Usual dose: 1 spray in each nostril once daily, preferably in the morning. If necessary, 2 sprays in each nostril once daily or 1 spray in each nostril bid. Then, patient may shift to usual dose once adequate control is achieved. Max: 2 sprays in each nostril daily.

Click to view Nasoflo detailed prescribing information

Overdosage

View Nasoflo overdosage for action to be taken in the event of an overdose.

Contraindications

Hypersensitivity.

Click to view Nasoflo detailed prescribing information

Special Precautions

May cause growth velocity reduction in childn. Avoid taking higher than recommended doses. Patients who receive systemic corticosteroids for prolonged periods & transferred to topical corticosteroids. Possibility of Cushing's syndrome in patients sensitive to corticosteroid effects or when usual doses are exceeded. Avoid exposure to allergens during treatment to prevent occurrence of severe allergic symptoms in the eyes &/or lower resp tract. Caution use in patient w/ clinical TB or asymptomatic M. tuberculosis infection of the resp tract, untreated fungal or bacterial infection, ocular herpes simplex or untreated systemic viral infection. Examine nasal passages periodically for mucosal changes & signs of candidiasis during long-term therapy. Increased susceptibility to infections (eg, chickenpox, varicella). Concomitant use w/ other inhaled steroids. Pregnancy & lactation. Elderly. Childn <4 yr.

Click to view Nasoflo detailed prescribing information

Use In Pregnancy & Lactation

Click to view Nasoflo detailed prescribing information

Adverse Reactions

Immediate hypersensitivity reactions & anaphylaxis/anaphylactoid reaction; epistaxis, nasal burning/irritation, pharyngitis, cough, asthma symptoms, nasal secretion containing blood, nasal discharge, bronchitis, sneezing, rhinorrhea, sinusitis, sore throat, throat irritation & dryness, hoarseness, voice changes, alteration or loss of sense of taste &/or smell, nasal congestion, nasal dryness, nasal septum perforation, nasal septum crusting, nasal ulcer & localized candidal infection of the nose &/or pharynx; nausea, vomiting, abdominal pain, diarrhea; dryness & irritation of the eyes, conjunctivitis, blurred vision, glaucoma, increased IOP & cataract; headache, dizziness, drowsiness, lethargy, fatigue or arthralgia, fever, flu-like symptoms, menstrual cramps, aches & pains, growth suppression.

Click to view Nasoflo detailed prescribing information

Drug Interactions

Increased risk of hypercorticism &/or suppression of HPA axis function w/ other inhaled or systemic corticosteroids. Increased peak plasma conc & AUC w/ ritonavir. Increased plasma conc w/ ketoconazole & other CYP3A4 inhibitors.

Click to view Nasoflo detailed prescribing information

Caution For Usage

For caution against possible variation of physical aspect of medicine... Click to view Nasoflo detailed prescribing information

Storage

View Nasoflo storage conditions for details to ensure optimal shelf-life.

Description

View Nasoflo description for details of the chemical structure and excipients (inactive components).

Action

View Nasoflo mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Nasal Decongestants & Other Nasal Preparations

ATC Classification

R01AD08 - fluticasone ; Belongs to the class of topical corticosteroids used for prophylaxis and treatment of allergic rhinitis.

Regulatory Classification

Presentation/Packing

Form

Nasoflo nasal spray 50 mcg

Packing/Price

(aqueous) 120 spray x 1's (P490.57/container)

Nasoflo

fluticasone

Manufacturer:

UNILAB, Inc

Distributor:

UNILAB, Inc